2023
DOI: 10.1080/00365513.2023.2233890
|View full text |Cite
|
Sign up to set email alerts
|

The prognostic impact of inflammation in patients with decompensated acute heart failure, as assessed using the pan-immune inflammation value (PIV)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…retrospectively analyzed the association between increased PIV and adverse outcomes, including worse overall survival (HR: 4.46, 95%CI: 2.22-8.99) and progression-free survival (HR: 2.03, 95% CI: 1.08-3.80), besides, resistance to platinum-based chemotherapy in patients with advanced triple-negative breast cancer ( 20 ). Furthermore, PIV has also been discovered as a novel biomarker in reflecting the association between inflammation and noncancer diseases, such as in hypertension, heart failure, myocardial infarction, kidney disease, frailty, and hepatic steatosis ( 13 , 24 28 ). Similarly, elevated PIV level correlated with the presence and severity of these noncancerous conditions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…retrospectively analyzed the association between increased PIV and adverse outcomes, including worse overall survival (HR: 4.46, 95%CI: 2.22-8.99) and progression-free survival (HR: 2.03, 95% CI: 1.08-3.80), besides, resistance to platinum-based chemotherapy in patients with advanced triple-negative breast cancer ( 20 ). Furthermore, PIV has also been discovered as a novel biomarker in reflecting the association between inflammation and noncancer diseases, such as in hypertension, heart failure, myocardial infarction, kidney disease, frailty, and hepatic steatosis ( 13 , 24 28 ). Similarly, elevated PIV level correlated with the presence and severity of these noncancerous conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Recent years, the focus of PIV-related research has mainly centered on its implications for the prognosis and therapeutic outcomes in oncological patients (11,12,(18)(19)(20)(21)(22)(23) (20). Furthermore, PIV has also been discovered as a novel biomarker in reflecting the association between inflammation and noncancer diseases, such as in hypertension, heart failure, myocardial infarction, kidney disease, frailty, and hepatic steatosis (13,(24)(25)(26)(27)(28). Similarly, elevated PIV level correlated with the presence and severity of these noncancerous conditions.…”
mentioning
confidence: 99%